Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Economics & Policy: Should the FDA address potential heart damage from energy drinks? | Casana raises $14M
Monday, February 22, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Economics

Energy drinks may damage the heart, researchers warn—should the FDA get involved?

The authors assessed 17 popular energy drinks, sharing their analysis in Food and Chemical Toxicology. 

READ MORE >
Sen. Chunk Schumer has asked the U.S. Food and Drunk Administration (FDA) to investigate the high amount of caffeine found in energy drinks sold by Prime, a beverage brand founded by YouTube personalities Logan Paul and KSI. According to Schumer, the “eye-popping 200 mg of caffeine” found in a single Prime energy drink is troubling, especially for a product marketed primarily to children.
Share on Twitter Share on Facebook Share on Linkedin

Energy drinks may damage the heart, researchers warn—should the FDA get involved?

Share on Twitter Share on Facebook Share on Linkedin
Sen. Chunk Schumer has asked the U.S. Food and Drunk Administration (FDA) to investigate the high amount of caffeine found in energy drinks sold by Prime, a beverage brand founded by YouTube personalities Logan Paul and KSI. According to Schumer, the “eye-popping 200 mg of caffeine” found in a single Prime energy drink is troubling, especially for a product marketed primarily to children.
The authors assessed 17 popular energy drinks, sharing their analysis in Food and Chemical Toxicology. 
READ MORE >

Intelerad Medical Systems acquires Lumedx

Intelerad Medical Systems has acquired Lumedx, an Oakland, California-based healthcare technology company focused on analytics and cardiovascular information systems. This is Intelerad’s third acquisition in the last seven months.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Intelerad Medical Systems acquires Lumedx

Share on Twitter Share on Facebook Share on Linkedin
Intelerad Medical Systems has acquired Lumedx, an Oakland, California-based healthcare technology company focused on analytics and cardiovascular information systems. This is Intelerad’s third acquisition in the last seven months.
READ MORE >

CV Summit Virtual 2021: What does value-based care mean for cardiologist compensation?

Compensation for cardiologists has been ample in recent years. Could the healthcare industry’s growing interest in value over volume lead to a change in that trend?

READ MORE >
Money dollar investments
Share on Twitter Share on Facebook Share on Linkedin

CV Summit Virtual 2021: What does value-based care mean for cardiologist compensation?

Share on Twitter Share on Facebook Share on Linkedin
Money dollar investments
Compensation for cardiologists has been ample in recent years. Could the healthcare industry’s growing interest in value over volume lead to a change in that trend?
READ MORE >

Casana raises $14M to bring toilet seat-based heart monitoring system to market

Casana, formerly known as Heart Health Intelligence, also named a new CEO. 

READ MORE >
heart monitor toilet seat
Share on Twitter Share on Facebook Share on Linkedin

Casana raises $14M to bring toilet seat-based heart monitoring system to market

Share on Twitter Share on Facebook Share on Linkedin
heart monitor toilet seat
Casana, formerly known as Heart Health Intelligence, also named a new CEO. 
READ MORE >

Shockwave’s IVL technology gains FDA approval for treating advanced coronary artery disease

Shockwave Medical announced Tuesday, Feb. 16, that intravascular lithotripsy (IVL) has gained FDA approval for the treatment of severely calcified coronary artery disease.

READ MORE >
The Shockwave Medical M5+ new peripheral intravascular lithotripsy (IVL) catheter cuts procedures times in half and was showed for the first time at the American College of Cardiology (ACC) 2022 meeting. It is designed to break up calcium in heavily calcified arteries to avoid the need for vessel trauma caused by high pressure angioplasty.
Share on Twitter Share on Facebook Share on Linkedin

Shockwave’s IVL technology gains FDA approval for treating advanced coronary artery disease

Share on Twitter Share on Facebook Share on Linkedin
The Shockwave Medical M5+ new peripheral intravascular lithotripsy (IVL) catheter cuts procedures times in half and was showed for the first time at the American College of Cardiology (ACC) 2022 meeting. It is designed to break up calcium in heavily calcified arteries to avoid the need for vessel trauma caused by high pressure angioplasty.
Shockwave Medical announced Tuesday, Feb. 16, that intravascular lithotripsy (IVL) has gained FDA approval for the treatment of severely calcified coronary artery disease.
READ MORE >

Society of Cardiovascular Computed Tomography shares new CCTA guidance

The guidance, published in full in the Journal of Cardiovascular Computed Tomography, includes updates to previous CCTA recommendations and was designed to answer common questions.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Society of Cardiovascular Computed Tomography shares new CCTA guidance

Share on Twitter Share on Facebook Share on Linkedin
The guidance, published in full in the Journal of Cardiovascular Computed Tomography, includes updates to previous CCTA recommendations and was designed to answer common questions.
READ MORE >

FDA announces recall of Boston Scientific’s EMBLEM S-ICD Subcutaneous Electrode—26 injuries, 1 death reported

The FDA categorized this as a Class I recall, which means it is an especially serious issue that can result in injury or death.  

READ MORE >
Product Recall
Share on Twitter Share on Facebook Share on Linkedin

FDA announces recall of Boston Scientific’s EMBLEM S-ICD Subcutaneous Electrode—26 injuries, 1 death reported

Share on Twitter Share on Facebook Share on Linkedin
Product Recall
The FDA categorized this as a Class I recall, which means it is an especially serious issue that can result in injury or death.  
READ MORE >

USPSTF recommends against screening healthy adults for carotid artery stenosis

"Screening for CAS in adults without symptoms does more harm than good, and we continue to recommend against it," one USPSTF representative said. 

READ MORE >
Negative opinion
Share on Twitter Share on Facebook Share on Linkedin

USPSTF recommends against screening healthy adults for carotid artery stenosis

Share on Twitter Share on Facebook Share on Linkedin
Negative opinion
"Screening for CAS in adults without symptoms does more harm than good, and we continue to recommend against it," one USPSTF representative said. 
READ MORE >

Explained: 4 key takeaways from the 2020 ACC/AHA valvular heart disease guidelines

Two specialists have shared their own perspective on the updated ACC/AHA guidelines in Circulation.

READ MORE >
doctors.jpg
Share on Twitter Share on Facebook Share on Linkedin

Explained: 4 key takeaways from the 2020 ACC/AHA valvular heart disease guidelines

Share on Twitter Share on Facebook Share on Linkedin
doctors.jpg
Two specialists have shared their own perspective on the updated ACC/AHA guidelines in Circulation.
READ MORE >

CMS expands Medicare coverage for TMVR, now known as TEER, to include patients with functional MR

Abbott described the update as "critically important," and the American College of Cardiology expressed relief that some proposed changes did not actually end up happening. 

READ MORE >
Medicare Provider
Share on Twitter Share on Facebook Share on Linkedin

CMS expands Medicare coverage for TMVR, now known as TEER, to include patients with functional MR

Share on Twitter Share on Facebook Share on Linkedin
Medicare Provider
Abbott described the update as "critically important," and the American College of Cardiology expressed relief that some proposed changes did not actually end up happening. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme